Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of early antiretroviral therapy during primary HIV-1 infection
2004-000446-20Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Jun 2006
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of zidovudine, lamivudine, lopinavir and ritonavir in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Imperial College London. Started Jun 2006; status: completed.
02
Drugs
zidovudinelamivudinelopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-000446-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000446-20.